Clinical Trial Update: Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating adjuvant interferon alfa-2b following surgery in patients with stage III melanoma. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma (Skin) | Phase 3 | Status: UNKNOWN